Article Details
Retrieved on: 2024-11-18 13:03:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... monoclonal antibodies, cell and gene therapy and mRNA workflows,” Michael Stubblefield, Avantor president and CEO, said. “Working side-by-side ...
Article found on: pennbizreport.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here